Both in Pharmaceuticals
NRX Pharmaceuticals vs OnKure Therapeutics
Over the past year NRXP returned −23.2% and OKUR returned −21.7%; their daily moves had a correlation of 0.14.
NRXP −23.2% OKUR −21.7%Growth of $1, one year, split-adjusted
| Metric | NRXP | OKUR |
|---|---|---|
| Price | $2.19 | $2.56 |
| Market cap | $94.8M | $103.7M |
| Today | −3.52% | −2.29% |
| 1 month | −24.6% | 0.0% |
| 6 months | −27.0% | −44.3% |
| Year to date | −19.2% | −11.7% |
| 1 year | −27.5% | −23.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 38.7% | — |
| Net margin | −1500.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 27.9× | — |
| Net cash | $26.3M | $176.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.7% | 55.4% |
| Short % of float | 29.3% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).